Analgesics is one of 63 small molecule programs targeting Sedation. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
332 competitors in Treatment
Biltricide
Dexilant
Levulan
Alfenta
Niclocide
Minipress
Hivid
Clomid
Aurlumyn
Lotemax
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details